These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 34570947)

  • 21. SARS-CoV-2 seroprevalence in healthcare workers of a teaching hospital in a highly endemic region in the Netherlands after the first wave: a cross-sectional study.
    Bouwman M; van Osch F; Crijns F; Trienekens T; Mehagnoul-Schipper J; van den Bergh JP; de Vries J
    BMJ Open; 2021 Oct; 11(10):e051573. PubMed ID: 34663664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study.
    Brousseau N; Morin L; Ouakki M; Savard P; Quach C; Longtin Y; Cheng MP; Carignan A; Dufresne SF; Leduc JM; Lavallée C; Gauthier N; Bestman-Smith J; Arrieta MJ; Ishak M; Lévesque S; Martin P; De Serres G
    CMAJ; 2021 Dec; 193(49):E1868-E1877. PubMed ID: 34903591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain.
    Peremiquel-Trillas P; Saura-Lázaro A; Benavente-Moreno Y; Casabonne D; Loureiro E; Cabrera S; Duran A; Garrote L; Brao I; Trelis J; Galán M; Soler F; Julià J; Cortasa D; Domínguez MÁ; Albasanz-Puig A; Gudiol C; Ramírez-Tarruella D; Muniesa J; Rivas JP; Muñoz-Montplet C; Sedano A; Plans À; Calvo-Cerrada B; Calle C; Clopés A; Carnicer-Pont D; Alemany L; Fernández E
    BMJ Open; 2022 Apr; 12(4):e056637. PubMed ID: 35450905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina.
    Halili R; Bunjaku J; Gashi B; Hoxha T; Kamberi A; Hoti N; Agahi R; Basha V; Berisha V; Hoxha I
    BMC Infect Dis; 2022 Jan; 22(1):57. PubMed ID: 35034617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.
    Gupta R; Dwivedi T; Gajendra S; Sahoo B; Gupta SK; Vikas H; Singh AR; Mohan A; Bhatnagar S; Singh S; Wundavalli L; Guleria R
    Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):207-213. PubMed ID: 33642348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of anti-SARS-CoV-2 antibodies and risk of viral exposure among healthcare workers in the South Kivu province, eastern Democratic Republic of the Congo: a cross-sectional study.
    Chasinga TB; Cikwanine JB; Kribi S; Yoyu JT; Hofmann N; Grossegesse M; Nitsche A; Tomczyk S; Vietor AC; Leendertz FH; Eckmanns T; Kusinza AB; Munguakonkwa E; Kalk A; Raha M; Kambale NS; Ayagirwe RB; Schubert G; Mukwege D
    BMJ Open; 2024 Jan; 14(1):e072212. PubMed ID: 38176860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal SARS-CoV-2 Seroprevalence among Employees in Outpatient Care Services in Hamburg.
    Schablon A; Harth V; Terschüren C; Kleinmüller O; Wohlert C; Schnabel C; Brehm TT; Schulze Zur Wiesch J; Kersten JF; Nienhaus A
    Int J Environ Res Public Health; 2023 Apr; 20(8):. PubMed ID: 37107881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
    Allen N; Riain UN; Conlon N; Ferenczi A; Carrion Martin AI; Domegan L; Walsh C; Doherty L; O'Farrelly C; Higgins E; Kerr C; McGrath J; ; Fleming C; Bergin C
    Epidemiol Infect; 2021 Apr; 149():e157. PubMed ID: 33902786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis.
    Chen X; Chen Z; Azman AS; Deng X; Sun R; Zhao Z; Zheng N; Chen X; Lu W; Zhuang T; Yang J; Viboud C; Ajelli M; Leung DT; Yu H
    Lancet Glob Health; 2021 May; 9(5):e598-e609. PubMed ID: 33705690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The seroprevalence of SARS-CoV-2 during the first wave in Europe 2020: A systematic review.
    Vaselli NM; Hungerford D; Shenton B; Khashkhusha A; Cunliffe NA; French N
    PLoS One; 2021; 16(11):e0250541. PubMed ID: 34727115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global prevalence of mental health problems among healthcare workers during the Covid-19 pandemic: A systematic review and meta-analysis.
    Saragih ID; Tonapa SI; Saragih IS; Advani S; Batubara SO; Suarilah I; Lin CJ
    Int J Nurs Stud; 2021 Sep; 121():104002. PubMed ID: 34271460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff.
    Martin CA; Patel P; Goss C; Jenkins DR; Price A; Barton L; Gupta P; Zaccardi F; Jerina H; Duraisingham S; Brunskill NJ; Khunti K; Pareek M
    J Public Health (Oxf); 2022 Jun; 44(2):234-245. PubMed ID: 33200200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 seroprevalence in hospital healthcare workers in Western Switzerland at the end of the second pandemic wave.
    Jacot D; von Rotz U; Blondet F; Aebischer O; Matthieu P; De Rham M; Pantaleo G; Marchetti O; Greub G
    J Med Microbiol; 2022 Aug; 71(8):. PubMed ID: 35921229
    [No Abstract]   [Full Text] [Related]  

  • 34. [SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey].
    Özdemir A; Demir Çuha M; Telli Dizman G; Alp A; Metan G; Şener B
    Mikrobiyol Bul; 2021 Apr; 55(2):223-232. PubMed ID: 33882653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut.
    Papasavas P; Olugbile S; Wu U; Robinson K; Roberts AL; O'Sullivan DM; McLaughlin T; Mather JF; Steinberg AC; Orlando R; Kumar A
    J Hosp Infect; 2021 Aug; 114():117-125. PubMed ID: 33930487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of SARS-CoV-2 antibodies, associated factors, experiences and attitudes of nursing home and home healthcare employees in Switzerland.
    West EA; Kotoun OJ; Schori LJ; Kopp J; Kaufmann M; Rasi M; Fehr J; Puhan MA; Frei A;
    BMC Infect Dis; 2022 Mar; 22(1):259. PubMed ID: 35296242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [SARS-CoV-2 seroprevalence among workers in a hospital in Madrid.].
    Pérez-García F; Pérez-Zapata A; Arcos Varela N; de la Mata Herrera M; Ortiz García M; Simón Ramos E; Calero Barzano C; Clemente García B; García Miranda L; Martín Soto L; Ropero Martínez M; Barrabés Bayascas RM; Cuadros-González J
    Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34675168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective surveillance study in a 1,400-bed university hospital: COVID-19 exposure at home was the main risk factor for SARS-CoV-2 point seroprevalence among hospital staff.
    Bahrs C; Kimmig A; Weis S; Ankert J; Hagel S; Maschmann J; Stallmach A; Steiner A; Bauer M; Behringer W; Baier M; Kesselmeier M; Richert C; Zepf F; Walter M; Scherag A; Kiehntopf M; Löffler B; Pletz MW
    Transbound Emerg Dis; 2022 Mar; 69(2):720-730. PubMed ID: 33605549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of SARS-CoV-2 in healthcare workers from outpatient facilities and retirement or nursing homes in a Swiss canton.
    Zürcher K; Mugglin C; Suter-Riniker F; Keller PM; Egger M; Müller S; Fluri M; Hoffmann M; Fenner L
    Swiss Med Wkly; 2021 Aug; 151():w30021. PubMed ID: 34495604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Seroprevalence of SARS-CoV-2 Antibodies among HealthCare Workers in University Hospital in Krakow before the Era of Vaccination.
    Żółtowska B; Barańska I; Jachowicz E; Sydor W; Maziarz B; Mydel K; Różańska A; Wizner B; Rosiński J; Kossowska M; Głomb K; Wójkowska-Mach J
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.